newsfilter
← Latest News
GlobeNewswire·

Aerpio Announces Strategic Review after Topline Results from Razuprotafib Glaucoma Phase 2 Trial

CINCINNATI, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio” or the “Company”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2,...